Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review.
The Acute Respiratory Distress Syndrome (ARDS) is a devastating clinical condition that is associated with a 30-40% risk of death, and significant long term morbidity for those who survive. Mesenchymal stromal cells (MSC) have emerged as a potential novel treatment as in pre-clinical models they hav...
Main Authors: | Lauralyn A McIntyre, David Moher, Dean A Fergusson, Katrina J Sullivan, Shirley H J Mei, Manoj Lalu, John Marshall, Malcolm Mcleod, Gilly Griffin, Jeremy Grimshaw, Alexis Turgeon, Marc T Avey, Michael A Rudnicki, Mazen Jazi, Jason Fishman, Duncan J Stewart, Canadian Critical Care Translational Biology Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4731557?pdf=render |
Similar Items
-
The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research.
by: Marc T Avey, et al.
Published: (2016-01-01) -
Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
by: Manoj M Lalu, et al.
Published: (2016-11-01) -
Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials.
by: Manoj M Lalu, et al.
Published: (2012-01-01) -
Development of a Murine Model of Early Sepsis in Diet-Induced Obesity
by: Momina Khan, et al.
Published: (2014-01-01) -
Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol
by: Carly C. Barron, et al.
Published: (2017-11-01)